Physician

Daniel H. Miller, M.D.

According to 2025 Medicare claims, Daniel Miller, M.D. (NPI: 1447694922) practices radiation oncology in the Idaho Falls, ID market, with the plurality of this provider's patient population coming from Bonneville, ID. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 83404-7536. Miller is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), Aledade 151 Northern Territories MSSP Enhanced (ACO ID: A5349), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 1,491 HCPCS/CPT codes, and received $118,129 in Medicare payments. The top billing code was 77263 (Complex radiation therapy planning). Part D data shows 269 prescription claims across 87 beneficiaries totaling $10,147 in drug costs, led by Solifenacin Succinate (Solifenacin Succinate). Open Payments data shows 55 records totaling $1,247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,463 to $10,147. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	86	731	$51,205
2019	124	2,398	$155,523
2020	162	2,998	$198,292
2021	227	2,548	$185,675
2022	202	1,661	$123,152
2023	181	1,558	$99,001
2024	199	1,491	$118,129

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	34	$2,463
2016	19	26	$1,650
2017	N/R	N/R	N/R
2018	24	68	$2,596
2019	35	106	$1,409
2020	55	151	$2,337
2021	74	237	$6,038
2022	74	177	$27,500
2023	76	235	$9,005
2024	87	269	$10,147

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77263	Complex radiation therapy planning	56	63	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	164	$72
77334	Design and construction of complex radiation treatment device	40	132	$48
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	86	104	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	53	64	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Solifenacin Succinate	Solifenacin Succinate	16	790	$549
Tamsulosin Hcl	Tamsulosin Hcl	38	2,535	$379
Pantoprazole Sodium	Pantoprazole Sodium	18	751	$148
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	84	$123
Methylprednisolone	Methylprednisolone	15	90	$79

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$1,247	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel H. Miller, M.D.?

Tedicare shows public-source Medicare data for Daniel H. Miller, M.D. (NPI 1447694922), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel H. Miller, M.D. have ACO affiliation data?

Daniel H. Miller, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), Aledade 151 Northern Territories MSSP Enhanced (MSSP, ACO ID A5349), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Daniel H. Miller, M.D.?

Daniel H. Miller, M.D. is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Daniel H. Miller, M.D. have Open Payments data?

Daniel H. Miller, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.